Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Diseases, Disorders & Medical XenoTherapeutics Inc

XenoTherapeutics Inc

Fiscal year ending 2024. Filed on March 12, 2025.

923 Elm Street 72
Manchester, New Hampshire 03101

XenoTherapeutics Inc (EIN: 81-1016095) has filed an IRS Form 990 since fiscal year 2020. In its fiscal year 2024 IRS Form 990 filing, XenoTherapeutics Inc, a 501(c)(3) charitable organization, reported compensation for 6 employees. Among the employees shown here, the average compensation is $164,887. The highest compensated employee at XenoTherapeutics Inc is Jon Adkins with fiscal year 2024 compensation of $168,557.

Revenue, expenses, and employee compensation

Revenue

$4,224,636

Expenses

$3,113,717

Employee compensation

—
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Jon Adkins
President and Chief Executive Officer
$168,557
$168,557 No related compNo other comp
Jamie Love
Chief Financial Officer and Treasurer
$161,216
$145,496 No related comp$15,720
Dr Dicken Ko
Clerk
$0
Mark Nedelman
Trustee
$0
William Deacon
Chair
$0
Ruta Laukien
Trustee
$0

Benchmark Employee Compensation

Revisions to this organization profile

March 12, 2025:
2024 XenoTherapeutics Inc 990 filed
November 1, 2024:
2023 XenoTherapeutics Inc 990 filed
March 7, 2023:
2022 XenoTherapeutics Inc 990 filed

Get an email when new compensation information is released for XenoTherapeutics Inc

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →